The Boston Heart HDL Map® test measures the five most significant HDL subpopulations in CVD risk, as well as HDL-C, triglycerides, and Apo A1. It provides information to identify patients at an increased risk of developing cardiovascular disease. Please be advised that Boston Heart Diagnostics policy states that practitioners cannot order labs on themselves or their immediate family member
